SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Taddeo F.)
 

Search: WFRF:(Taddeo F.) > (2006-2009) > Prophylactic effica...

  • Villa, Luisa L. (author)

Prophylactic efficacy of a quadrivalent human papillomavirus (HPV) vaccine in women with virological evidence of HPV infection

  • Article/chapterEnglish2007

Publisher, publication year, extent ...

  • Oxford University Press (OUP),2007

Numbers

  • LIBRIS-ID:oai:lup.lub.lu.se:c0f2b2b7-2f15-4dbf-9928-2b4bd278c00c
  • https://lup.lub.lu.se/record/969027URI
  • https://doi.org/10.1086/522864DOI
  • http://kipublications.ki.se/Default.aspx?queryparsed=id:116232722URI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:art swepub-publicationtype
  • Subject category:ref swepub-contenttype

Notes

  • Background. A quadrivalent (types 6, 11, 16, and 18) human papillomavirus (HPV) L1 virus-like-particle (VLP) vaccine has been shown to be 95%-100% effective in preventing cervical and genital disease related to HPV-6,-11,-16, and-18 in 16-26-year-old women naive for HPV vaccine types. Because most women in the general population are sexually active, some will have already been infected with >= 1 HPV vaccine types at the time vaccination is offered. Here, we assessed whether such infected women are protected against disease caused by the remaining HPV vaccine types. Methods. Two randomized, placebo-controlled trials of the quadrivalent (types 6, 11, 16, and 18) HPV vaccine enrolled 17,622 women without consideration of baseline HPV status. Among women infected with 1-3 HPV vaccine types at enrollment, efficacy against genital disease related to the HPV vaccine type or types for which subjects were naive was assessed. Results. Vaccination was 100% effective (95% confidence interval [CI], 79%-100%) in preventing incident cervical intraepithelial neoplasia 2 or 3 or cervical adenocarcinoma in situ caused by the HPV type or types for which the women were negative at enrollment. Efficacy for preventing vulvar or vaginal HPV-related lesions was 94% (95% CI, 81%-99%). Conclusions. Among women positive for 1-3 HPV vaccine types before vaccination, the quadrivalent HPV vaccine protected against neoplasia caused by the remaining types. These results support vaccination of the general population without prescreening.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Perez, Gonzalo (author)
  • Kjaer, Susanne Krueger (author)
  • Paavonen, Jorma (author)
  • Lehtinen, Matti (author)
  • Munoz, Nubia (author)
  • Sigurdsson, Kristjan (author)
  • Hernandez-Avila, Mauricio (author)
  • Iversen, Ole Eric (author)
  • Thoresen, Steinar (author)
  • Garcia, Patricia J. (author)
  • Majewski, Slawomir (author)
  • Tay, Eng Hseon (author)
  • Bosch, F. Xavier (author)
  • Dillner, JoakimKarolinska Institutet,Lund University,Lunds universitet,Klinisk mikrobiologi, Malmö,Forskargrupper vid Lunds universitet,Clinical Microbiology, Malmö,Lund University Research Groups(Swepub:lu)mikr-jdi (author)
  • Olsson, Sven-EricKarolinska Institutet (author)
  • Ault, Kevin A. (author)
  • Brown, Darron R. (author)
  • Ferris, Daron G. (author)
  • Koutsky, Laura A. (author)
  • Kurman, Robert J. (author)
  • Myers, Evan R. (author)
  • Barr, Eliav (author)
  • Boslego, John (author)
  • Bryan, Janine (author)
  • Esser, Mark T. (author)
  • Hesley, Teresa M. (author)
  • Nelson, Micki (author)
  • Railkar, Radha (author)
  • James, Margaret (author)
  • Sattler, Carlos (author)
  • Taddeo, Frank J. (author)
  • Thornton, Annemarie R. (author)
  • Vuocolo, Scott C. (author)
  • Klinisk mikrobiologi, MalmöForskargrupper vid Lunds universitet (creator_code:org_t)

Related titles

  • In:Journal of Infectious Diseases: Oxford University Press (OUP)196:10, s. 1438-14461537-66130022-1899

Internet link

Find in a library

To the university's database

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view